Galena taps Teva to handle global distribution and commercialization of NeuVax; U.K. whooping cough cases are 10 times the number in the last peak;

 @AlisonBFierce: DARPA will try where others have failed. The agency aims to develop a DNA vaccine. More | Follow @AlisonBFierce

> Galena Biopharma ($GALE) announced that Teva Pharmaceutical Industries ($TEVA) will handle global distribution and commercialization of NeuVax. Story

> Whooping cough cases in the U.K. this year are 10 times the number seen in the last peak year for the illness in 2008. Report

> Doctors and scientists say upping the rate of flu vaccinations to 80% could significantly reduce outbreaks or wipe out the virus entirely. Story

> Novavax ($NVAX) published a preclinical efficacy study of its RSV fusion protein nanoparticle vaccine candidate. Release

And Finally... Vical ($VICL) licensed its Vaxfectin adjuvant to Cyvax for use in malaria vaccines. Release